Cidara Therapeutics Inc buy Reibach111
Start price
23.07.17
/
50%
€7.17
Target price
23.01.18
€9.02
Performance (%)
-4.72%
End price
23.01.18
€6.83
Summary
This prediction ended on 23.01.18 with a price of €6.83. With a performance of -4.72%, the BUY prediction by Reibach111 finished with a loss. Reibach111 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cidara Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by Reibach111 for this prediction
In the thread Cidara Therapeutics Inc diskutieren
Reibach111 stimmt dem Crowdsentiment von 'Buy' zu
Reibach111 stimmt am 23.07.2017 dem Buy-Crowdsentiment mit dem Kursziel 8.7$ zu.
(Laufzeit überschritten)